Preventive effect of TAK-751S on complications of hemorrhagic colitis (results of clinical study of TAK-751S)

Japanese Journal of Antibiotics

Volumn 55, Issue 2, 2002, Pages 203-227

  Ito, Hiroshi ^a   Takeda, Tae ^a   Honda, Masataka ^a   Igarashi, Takashi ^a   Joh, Kosuke ^a   Hashizume, Takao ^a   Yamaoka, Kanji ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADSORBENT; SHIGA TOXIN; TAK 751S; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; BRAIN DISEASE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; ENTEROBACTER INFECTION; FEMALE; HEMOLYTIC UREMIC SYNDROME; HEMORRHAGIC COLITIS; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PHASE 2 CLINICAL TRIAL; SKIN DISEASE; SWEATING;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; COLITIS; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI O157; FEMALE; HEMOLYTIC-UREMIC SYNDROME; HUMANS; INFANT; MALE; NEUROTOXICITY SYNDROMES; ORGANOSILICON COMPOUNDS; TREATMENT OUTCOME; TRISACCHARIDES;

EID: 0036255889     PISSN: 03682781     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. A biotyping scheme for shiga-like (Vero) toxin-producing Escherichia coli O157 and a list of serological cross-reactions between O157 and other gram-negative bacteria
2. Guideline for diagnosis and treatment of HUS associated with enterohemorrhagic E. coli infection
3. Hamolytish-uremische syndrome: Bilaterale Nierenindennekrosen bei Akuten erworbenen Hamolytischen Anamien
4. The hemolytic uremic syndrome
5. Spectrum of extrarenal involvement in postdiarrheal hemolytic-uremic syndrome
6. Hemolytic uremic syndrome during an outbreak of E. coli O157:H7 infection in institutions for the retarded: Clinical and epidemiologic
7. Effect of subinhibitory concentrations of antibiotics on extracellular Shiga-like toxin I
8. The stimulating effect of fosfomycin, an antibiotic in common use in Japan, on the production/release of verotoxin-1 from enterohaemorrhagic Escherichia coli, O157:H7 in vitro
9. The role of antibiotics in the management of verotoxin-associated hemolytic anemia syndrome
10. Randomized, controlled trial of antibiotic therapy for Escherichia coli O157:H 7 enteritis
11. Risk factors for the progression of Escherichia coli O157:H7 enteritis to hemolytic-uremic syndrome
12. Investigation of Shiga-like toxin binding to chemically synthesized oligosaccharide sequences
13. A phase I study of chemically synthesized verotoxin (Shiga-like toxin) Pk-trisaccharide receptors attached to chromosorb for preventing hemolytic-uremic syndrome
14. The mode of action of Shiga toxin on peptide elongation of eukaryotic protein synthesis
15. Verotoxin glycolipid receptors determine the localization of microangiopathic process in rabbits given verotoxin-1
16. Shiga toxin-associated hemolytic uremic syndrome: Combined cytotoxic effects of Shiga toxin and lipopolysaccharide (endotoxin) on human vascular endotherial cells in vitro
17. Lipopolysaccharide-mediated bovine endotherial cell injury in vitro
18. Hemoglobin enhances the production of tissue factor by endotherial cells in response to bacterial endotoxin